Dashboard
Manage Tickers

EVOK


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

evoke-pharma-shares-halted-to-the-downside-stock-now-down--790
Evoke Pharma Shares Halted To The Downside...
08/20/2024 13:57:15

evoke-pharma-q2-eps-093-misses-006-estimate-sales-255m-miss-298m-estimate
Evoke Pharma Q2 EPS $(0.93) Misses $(0.06)...
08/13/2024 12:23:31

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.93) per share which missed the analyst consensus estimate of $(0.06...

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
07/31/2024 23:50:04

why-evoke-pharma-evok-stock-is-volatile
Why Evoke Pharma (EVOK) Stock Is Volatile
07/30/2024 21:22:08

Evoke Pharma shares were trading lower by 21.4% during Tuesday's session. The company announced a 1-for-12 reverse stock sp...

evoke-pharma-announces-1-for-12-reverse-stock-split-effective-august-1-2024
Evoke Pharma Announces 1-For-12 Reverse St...
07/30/2024 12:31:54

Common Stock To Trade On Split-Adjusted Basis Under Symbol EVOK With New CUSIP 30049G302

evoke-pharma-reports-commercial-strategy-progress--momentum-for-gimoti-announced-the-promotion-of-mark-kowieski-to-the-role-of-chief-financial-officer-in-may-2024
Evoke Pharma Reports Commercial Strategy P...
06/17/2024 12:41:36

Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024Promoted former VP...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/23/2024 20:31:02

evoke-pharma-presents-additional-gimoti-healthcare-utilization-data-focused-on-gastroparesis-care-insights-in-women-at-ddw-2024-conference
Evoke Pharma Presents Additional GIMOTI He...
05/16/2024 20:22:13

Evoke Pharma, Inc.(NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) d...

evoke-pharma-reiterates-fy24-net-revenue-14m-vs-14081-est
Evoke Pharma Reiterates FY24 Net Revenue ~...
05/14/2024 20:55:35

evoke-pharma-q1-2024-gaap-eps-017-beats-021-estimate-sales-174m-miss-214m-estimate
Evoke Pharma Q1 2024 GAAP EPS $(0.17) Beat...
05/14/2024 20:54:31

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.21) ...

evoke-pharma-announces-senior-leadership-transition-with-promotion-of-matthew-j-donofrio-to-chief-executive-officer-as-of-march-31-2024
Evoke Pharma Announces Senior Leadership T...
03/21/2024 20:28:34

Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) ...

evoke-pharma-sees-fy24-net-revenue-14m-vs-14017m-est
Evoke Pharma Sees FY24 Net Revenue ~$14M V...
03/14/2024 20:50:06

recap-evoke-pharma-q4-earnings
Recap: Evoke Pharma Q4 Earnings
03/14/2024 20:35:20

evoke-pharma-q4-2023-gaap-eps-059-misses-050-estimate-sales-1676m-beat-1632m-estimate
Evoke Pharma Q4 2023 GAAP EPS $(0.59) Miss...
03/14/2024 20:31:03

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.50...

earnings-scheduled-for-march-14-2024
Earnings Scheduled For March 14, 2024
03/14/2024 09:52:13

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/13/2024 21:32:47

laurence-w-lytton-reports-in-13g-filing-a-999-stake-in-evoke-pharma
Laurence W. Lytton Reports In 13G Filing A...
03/13/2024 18:02:17

https://www.sec.gov/Archives/edgar/data/1105806/000093583624000282/evok13g.htm

a-preview-of-evoke-pharmas-earnings
A Preview Of Evoke Pharma's Earnings
03/13/2024 18:02:17

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/09/2024 13:06:11

evoke-pharma-has-priced-an-underwritten-public-offering-led-by-nantahala-capital-management-for-gross-proceeds-of-up-to-30m-million-which-includes-initial-upfront-funding-of-approximately-75m
Evoke Pharma Has Priced An Underwritten Pu...
02/09/2024 12:33:00

The offering is comprised of (i) 11,029,411 shares of common stock (or pre-funded warrants in lieu thereof), (ii) 11,029,411 Se...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION